Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Epigenetics Market by, Product
6.1 Overview
6.2 Enzymes
6.3 Instruments and Accessories
6.4 Reagents and Kits
6.4.1 Bisulfite Conversion Kit
6.4.2 ChIP Sequencing Kit
6.4.3 RNA Sequencing Kit
6.4.4 Whole Genomic Amplification Kit
6.4.5 Other Reagents and Kits
6.5 Service
6.6 Software


7 Global Epigenetics Market by, Method
7.1 Overview
7.2 Chromatin Structures
7.3 DNA Methylation
7.4 Histone Acetylation
7.5 Histone Methylation
7.6 Histone Modifications
7.7 Large non-coding RNA
7.8 MicroRNA Modification
7.9 Other Methods


8 Global Epigenetics Market by, Technique
8.1 Overview
8.2 Mass Spectrometry
8.3 Next-Generation Sequencing (NGS)
8.4 Polymerase Chain Reaction (PCR) & Quantitative Polymerase Chain Reaction (qPCR)
8.5 Sonication
8.6 Other Techniques
8.6.1 Magnetic Separators
8.6.2 Microarrays


9 Global Epigenetics Market by, End User
9.1 Overview
9.2 Academic and Research Institutions
9.3 Clinical Research
9.4 Contract Research Organizations (CROS)
9.5 Hospitals & Clinics
9.6 Pharmaceutical and Biotechnology Companies
9.7 Other End Users


10 Global Epigenetics Market by, Application
10.1 Overview
10.2 Oncology
10.3 Non-Oncology
10.3.1 Autoimmune Diseases
10.3.2 Cardiovascular Diseases
10.3.3 Central Nervous System (CNS)/Pain Diseases
10.3.4 Developmental Biology
10.3.5 Immunology
10.3.6 Metabolic Diseases
10.3.7 Other Applications


11 Global Epigenetics Market by, Geography
11.1 Overview
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 UK
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia
11.4.6 New Zealand
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 UAE
11.6.2 Saudi Arabia
11.6.3 Qatar
11.6.4 Iran
11.6.5 South Africa
11.6.6 Rest of Middle East & Africa


12 Key Developments


13 Company Profiling
13.1 Thermo Fisher Scientific Inc.
13.1.1 Business Overview
13.1.2 Product/Service Offering
13.1.3 Financial Overview
13.1.4 SWOT Analysis
13.1.5 Key Activities
13.2 Illumina, Inc.
13.3 PacBio
13.4 Abcam plc
13.5 Merck KGaA
13.6 Active Motif, Inc.
13.7 Bio-Rad Laboratories Inc.
13.8 Promega Corporation
13.9 Zymo Research Corporation
13.10 Diagenode SA
13.11 F. Hoffmann-La Roche Ltd
13.12 QIAGEN